UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 399

Sortiert nach

Phase II trial of R‐CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601

British journal of haematology, 2016-01, Vol.172 (2), p.208-218

2016

Volltextzugriff (PDF)

RB but not R‐HCVAD is a feasible induction regimen prior to auto‐HCT in frontline MCL: results of SWOG Study S1106

British journal of haematology, 2017-03, Vol.176 (5), p.759-769

2017

Volltextzugriff (PDF)

Multiple myeloma and family history of lymphohaematopoietic cancers: Results from the International Multiple Myeloma Consortium

British journal of haematology, 2016-10, Vol.175 (1), p.87-101

2016

Volltextzugriff (PDF)

Progenitor cell involvement is predictive of response to induction chemotherapy in paediatric acute myeloid leukaemia

British journal of haematology, 2003-11, Vol.123 (3), p.431-435

2003

Volltextzugriff (PDF)

Acute megakaryoblastic leukaemia with 3q inversion and elevated thrombopoietin (TSF): an autocrine role for TSF?

British journal of haematology, 1985-12, Vol.61 (4), p.687-694

1985

Volltextzugriff (PDF)

GATA‐1 is expressed in acute erythroblastic leukaemia

British journal of haematology, 1994-02, Vol.86 (2), p.410-412

1994

Volltextzugriff (PDF)

Sun sensitivity, indoor tanning and B‐cell non‐Hodgkin lymphoma risk among Caucasian women in Los Angeles County

British journal of haematology, 2017-04, Vol.177 (1), p.153-156

2017

Volltextzugriff (PDF)

Abnormalities of chromosome 12p13 and malignant proliferation of eosinophils: a nonrandom association

British journal of haematology, 1987-09, Vol.67 (1), p.25-31

1987

Volltextzugriff (PDF)

F‐18 FDG‐PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem‐cell transplantation for relapsed and refractory Hodgkin lymphoma

British journal of haematology, 2014-06, Vol.165 (6), p.793-800

2014

Volltextzugriff (PDF)

Event‐free survival at 24 months captures central nervous system relapse of systemic diffuse large B‐cell lymphoma in the immunochemotherapy era

British journal of haematology, 2018-10, Vol.183 (1), p.149-152

2018

Volltextzugriff (PDF)

Acute promyelocytic transformation of chronic myeloid leukaemia with an isochromosome 17q

British journal of haematology, 1986-12, Vol.64 (4), p.751-756

1986

Volltextzugriff (PDF)

Serological and biochemical analysis of the PlA1 alloantigen of human platelets

British journal of haematology, 1982-02, Vol.50 (2), p.351-359

1982

Volltextzugriff (PDF)

Tandem duplication of the FLT3 gene is found in acute lymphoblastic leukaemia as well as acute myeloid leukaemia but not in myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in children

British journal of haematology, 1999-04, Vol.105 (1), p.155-162

1999

Volltextzugriff (PDF)

Elevated plasma 2‐hydroxyglutarate in acute myeloid leukaemia: association with the IDH1 SNP rs11554137 and severe renal impairment

British journal of haematology, 2014-07, Vol.166 (1), p.145-148

2014

Volltextzugriff (PDF)

Non‐myeloablative allografting from human leucocyte antigen‐identical sibling donors for treatment of acute myeloid leukaemia in first complete remission

British journal of haematology, 2003-01, Vol.120 (2), p.281-288

2003

Volltextzugriff (PDF)

Phase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non‐Hodgkin lymphoma

British journal of haematology, 2009-10, Vol.147 (1), p.89-96

2009

Volltextzugriff (PDF)

Autografting with CD34+ peripheral blood stem cells: retained engraftment capability and reduced tumour cell content

British journal of haematology, 1999-02, Vol.104 (2), p.382-391

1999

Volltextzugriff (PDF)

Randomised comparison of two B‐cell purging protocols for patients with B‐cell non‐Hodgkin lymphoma: in vivo purging with rituximab versus ex vivo purging with CliniMACS CD34+ cell enrichment device

British journal of haematology, 2006-01, Vol.132 (1), p.42-55

2006

Volltextzugriff (PDF)

Polycythaemia vera. III. Burst‐forming units‐erythroid (BFU‐E) response to stem cell factor and c‐kit receptor expression

British journal of haematology, 1994-01, Vol.86 (1), p.12-21

1994

Volltextzugriff (PDF)

Unusual immunophenotypes in acute leukaemias: incidence and clinical correlations

British journal of haematology, 1989-08, Vol.72 (4), p.512-518

1989

Volltextzugriff (PDF)

Myeloid progenitor surface antigen identified by monoclonal antibody

British journal of haematology, 1985-09, Vol.61 (1), p.11-20

1985

Volltextzugriff (PDF)

Clinical activity of carfilzomib correlates with inhibition of multiple proteasome subunits: application of a novel pharmacodynamic assay

British journal of haematology, 2016-06, Vol.173 (6), p.884-895

2016

Volltextzugriff (PDF)

Rituximab plus hyper‐CVAD alternating with MTX/Ara‐C in patients with newly diagnosed mantle cell lymphoma: 15‐year follow‐up of a phase II study from the MD Anderson Cancer Center

British journal of haematology, 2016-01, Vol.172 (1), p.80-88

2016

Volltextzugriff (PDF)

Are dynamic or fixed FDG‐PET measures of disease of greater prognostic value in patients with relapsed/refractory diffuse large B‐cell lymphoma undergoing autologous haematopoietic stem cell transplantation?

British journal of haematology, 2023-05, Vol.201 (3), p.502-509

2023

Volltextzugriff (PDF)

Central nervous system involvement in AIDS‐related lymphomas

British journal of haematology, 2016-06, Vol.173 (6), p.857-866

2016

Volltextzugriff (PDF)

1 – 25 von 399

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

KollektionWiley Blackwell Single Titles

Zeitschrift / SerieBritish Journal Of Haematology

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(399)
Mit Volltextzugriff
(291)

Publikationsform

Artikel
(399)

Sprache

Englisch
(399)

Erscheinungsjahr

n.n

Thema

Hematology
(358)
Life Sciences & Biomedicine
(350)
Science & Technology
(350)
Biological And Medical Sciences
(268)
Medical Sciences
(255)
Male
(210)
Female
(206)
Hematologic And Hematopoietic Diseases
(204)
Middle Aged
(167)
Adult
(166)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(164)
Aged
(135)
Adolescent
(89)
Treatment Outcome
(74)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(72)
Child
(70)
Aged, 80 And Over
(57)
Prognosis
(47)
Acute Disease
(45)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Br J Haematol
(15)

Menü

Weitere Dienste

Einstellungen

Phase II trial of R‐CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601

RB but not R‐HCVAD is a feasible induction regimen prior to auto‐HCT in frontline MCL: results of SWOG Study S1106

Multiple myeloma and family history of lymphohaematopoietic cancers: Results from the International Multiple Myeloma Consortium

Progenitor cell involvement is predictive of response to induction chemotherapy in paediatric acute myeloid leukaemia

Acute megakaryoblastic leukaemia with 3q inversion and elevated thrombopoietin (TSF): an autocrine role for TSF?

GATA‐1 is expressed in acute erythroblastic leukaemia

Sun sensitivity, indoor tanning and B‐cell non‐Hodgkin lymphoma risk among Caucasian women in Los Angeles County

Abnormalities of chromosome 12p13 and malignant proliferation of eosinophils: a nonrandom association

F‐18 FDG‐PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem‐cell transplantation for relapsed and refractory Hodgkin lymphoma

Event‐free survival at 24 months captures central nervous system relapse of systemic diffuse large B‐cell lymphoma in the immunochemotherapy era

Acute promyelocytic transformation of chronic myeloid leukaemia with an isochromosome 17q

Serological and biochemical analysis of the PlA1 alloantigen of human platelets

Tandem duplication of the FLT3 gene is found in acute lymphoblastic leukaemia as well as acute myeloid leukaemia but not in myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in children

Elevated plasma 2‐hydroxyglutarate in acute myeloid leukaemia: association with the IDH1 SNP rs11554137 and severe renal impairment

Non‐myeloablative allografting from human leucocyte antigen‐identical sibling donors for treatment of acute myeloid leukaemia in first complete remission

Phase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non‐Hodgkin lymphoma

Autografting with CD34+ peripheral blood stem cells: retained engraftment capability and reduced tumour cell content

Randomised comparison of two B‐cell purging protocols for patients with B‐cell non‐Hodgkin lymphoma: in vivo purging with rituximab versus ex vivo purging with CliniMACS CD34+ cell enrichment device

Polycythaemia vera. III. Burst‐forming units‐erythroid (BFU‐E) response to stem cell factor and c‐kit receptor expression

Unusual immunophenotypes in acute leukaemias: incidence and clinical correlations

Myeloid progenitor surface antigen identified by monoclonal antibody

Clinical activity of carfilzomib correlates with inhibition of multiple proteasome subunits: application of a novel pharmacodynamic assay

Rituximab plus hyper‐CVAD alternating with MTX/Ara‐C in patients with newly diagnosed mantle cell lymphoma: 15‐year follow‐up of a phase II study from the MD Anderson Cancer Center

Are dynamic or fixed FDG‐PET measures of disease of greater prognostic value in patients with relapsed/refractory diffuse large B‐cell lymphoma undergoing autologous haematopoietic stem cell transplantation?

Central nervous system involvement in AIDS‐related lymphomas

Aktive Filter

Suchergebnisse filtern